About 7 Trademarks found that are owned by Arce TherapeutIcs Inc.

Biological research; conducting clinical trials for others; medical research; platform as a service (PAAS) featuring cell bioprocess platforms in the nature of computer software platforms for gene modified immune cells as therapeutic agents; research and development of new products for others; scientific laboratory services; scientific research in the field of cancers, autoimmune diseases, inflammatory diseases, neurodegenerative diseases, and immunotherapy; software as a service (SAAS) services featuring software for governing machineries for cell bioprocessing

The mark consists of a design feature resembling an irregular tube twisted into a shape of two asymmetric triangles pointing to each other.

The mark consists of the stylized wording "DashCAR".

ONE CAR

MAX CAR

Biological preparations for medical purposes, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological preparations for veterinary purposes for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological tissue cultures for medical purposes, namely, human blood samples, human allograft tissues, human umbilical cord blood and human induced pluripotent stem cells (iPSCs) from somatic cells; biological tissue cultures for veterinary purposes, namely, animal blood samples, tumors and allograft tissues; blood for medical purposes; cultures of microorganisms for medical or veterinary use; diagnostic biomarker reagents for medical purposes, namely, chemical and biological reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; pharmaceuticals, namely, drugs for medical purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; enzymes for medical purposes; enzymes for veterinary purposes; immunostimulants; medicinal infusions for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for human purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for veterinary purposes, namely, for veterinary cancers; preparations of microorganisms for medical or veterinary use, namely, cultures of bacteria and viruses for medical or veterinary use; pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceutical preparations, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals in the nature of pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; transplants comprised of living cells, namely, genetically engineered tissues for medical and transplant purposes; genetically engineered cells for medical purposes, specifically for transplantation purposes; vaccines

Biological preparations for medical purposes, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological preparations for veterinary purposes for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological tissue cultures for medical purposes, namely, human blood samples, human allograft tissues, human umbilical cord blood and human induced pluripotent stem cells (iPSCs) from somatic cells; biological tissue cultures for veterinary purposes, namely, animal blood samples, tumors and allograft tissues; blood for medical purposes; cultures of microorganisms for medical or veterinary use; diagnostic biomarker reagents for medical purposes, namely, chemical and biological reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; pharmaceuticals, namely, drugs for medical purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; enzymes for medical purposes; enzymes for veterinary purposes; immunostimulants; medicinal infusions for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for human purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for veterinary purposes, namely, for veterinary cancers; preparations of microorganisms for medical or veterinary use, namely, cultures of bacteria and viruses for medical or veterinary use; pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceutical preparations, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals in the nature of pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; transplants comprised of living cells, namely, genetically engineered tissues for medical and transplant purposes; genetically engineered cells for medical purposes, specifically for transplantation purposes; vaccines